Related references
Note: Only part of the references are listed.High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations
Emilia Jesien-Lewandowicz et al.
CANCER GENETICS AND CYTOGENETICS (2009)
Association Between MGMT Promoter Hypermethylation and p53 Mutation in Glioblastoma
Jamal Shamsara et al.
CANCER INVESTIGATION (2009)
Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target
Randy L. Jensen
JOURNAL OF NEURO-ONCOLOGY (2009)
p53 Mutant Human Glioma Cells Are Sensitive to UV-C-Induced Apoptosis Due to Impaired Cyclobutane Pyrimidine Dimer Removal
Luis F. Z. Batista et al.
MOLECULAR CANCER RESEARCH (2009)
Brain tumor imaging in clinical trials
J. W. Henson et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide
Walter Taal et al.
CANCER (2008)
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients
Alba A. Brandes et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Dieto Brandsma et al.
LANCET ONCOLOGY (2008)
MGMT in primary and recurrent human glioblastomas after radiation and chemotherapy and comparison with p53 status and clinical outcome
Dorothee Wiewrodt et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Interpretation of early imaging after concurrent radiotherapy and temozolomide for glioblastoma
S. Jefferies et al.
CLINICAL ONCOLOGY (2007)
Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O-6-methylguanine
W. P. Roos et al.
ONCOGENE (2007)
Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma
Marc C. Chamberlain et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells
M Hermisson et al.
JOURNAL OF NEUROCHEMISTRY (2006)
p53 as a target for anti-cancer drug development
Benjamin Pierre Bouchet et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
Apoptosis and proliferation: correlation with p53 in astrocytic tumours
C Sarkar et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
O6-Methylguanine-DNA Methyltransferase methylation and TP53 mutation in malignant astrocytomas and their relationships with clinical course
T Watanabe et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Endothelial cells Co-cultured with wild-type and dominant/negative p53-transfected glioblastoma cells exhibit differential sensitivity to radiation-induced apoptosis
NN Khodarev et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression
MCY de Wit et al.
NEUROLOGY (2004)
P53 alterations in colon tumors - A comparison of SSCP/sequencing and immunohistochemistry
K Curtin et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2004)
Influence of p53 mutations on prognosis of patients with glioblastoma
S Shiraishi et al.
CANCER (2002)
Impact of genotype and morphology on the prognosis of glioblastoma
MC Schmidt et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
The dependence of p53 on the radiation enhancement of thermosensitivity at different LET
A Takahashi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Share Paper
